Advertisement

Photodynamic Therapy and Inflammatory Disorders

  • Cara Garretson
  • Amy Forman TaubEmail author
Chapter

Abstract

While still in its infancy, photodynamic therapy is becoming a prominent treatment option in a number of dermatological diseases, such as psoriasis, lichen planus, lichen sclerosis, morphea/scleroderma, vitiligo, necrobiosis, lipoidica diabeticorum, sarcoidosis, granuloma annulare, alopecia areata, and Darier’s disease. Given the breadth of clinical implications, it is clear that both basic science and clinical studies are still needed to learn more about the mechanism of action, efficacy, and optimal treatment regimens in many of these inflammatory disorders.

Keywords

Salicylic Acid Methylene Blue Actinic Keratose Plaque Psoriasis Alopecia Areata 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hongcharu W, Taylor C, Chang Y, et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183–92.PubMedCrossRefGoogle Scholar
  2. 2.
    Pollock B, Turner D, Stringer M, et al. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol. 2004;151:616–22.PubMedCrossRefGoogle Scholar
  3. 3.
    Goldman M, Boyce S. A single-center study of aminolevulinic acid and 417 NM photodynamic therapy in the treatment of moderate to severe acne vulgaris. J Drugs Dermatol. 2003;2:393–6.PubMedGoogle Scholar
  4. 4.
    Taub AF. Photodynamic therapy for the treatment of acne: a pilot study. J Drugs Dermatol. 2004;3(6 Suppl):S10–4.PubMedGoogle Scholar
  5. 5.
    Bos JD. The pathomechanisms of psoriasis; the skin immune system and cyclosporin. Br J Dermatol. 1988;118(2):141–55.PubMedCrossRefGoogle Scholar
  6. 6.
    Boehncke WH, Konig K, Kaufmann R, et al. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res. 1994;286(6):300–3.PubMedCrossRefGoogle Scholar
  7. 7.
    Bissonnette R, Tremblay JF, Juzenas P, et al. Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. J Invest Dermatol. 2002;119(1):77–83.PubMedCrossRefGoogle Scholar
  8. 8.
    Wrone-Smith T, Mitra RS, Thompson CB, et al. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol. 1997;151:1321–9.PubMedGoogle Scholar
  9. 9.
    Smits T, Kleinpenning MM, van Erp PE, van de Kerkhof PC, Gerritsen MJ. A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis. Br J Dermatol. 2006;155(2):429–36.PubMedCrossRefGoogle Scholar
  10. 10.
    Stringer MR, Collins P, Robinson DJ, Stables GI, Sheehan-Dare RA. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol. 1996;107(1):76–81.PubMedCrossRefGoogle Scholar
  11. 11.
    Bissonnette R, Zeng H, McLean DI, et al. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells. Photochem Photobiol. 2001;74(2):339–45.PubMedCrossRefGoogle Scholar
  12. 12.
    Kleinpenning MM, Smits T, Ewalds E, van Erp PE, van de Kerkhof PC, Gerritsen MJ. Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study. Br J Dermatol. 2006;155(3):539–45.PubMedCrossRefGoogle Scholar
  13. 13.
    Kleinpenning MM, Kanis JH, Smits T, Van Erp PE, Van de Kerkhof P, Gerritsen RM. The effects of keratolytic pretreatment prior to fluorescence diagnosis and photodynamic therapy with aminolevulinic acid-induced porphyrins in psoriasis. J Dermatolog Treat. 2010;21:245–51.PubMedGoogle Scholar
  14. 14.
    Smits T, Robles CA, van Erp PE, et al. Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. J Invest Dermatol. 2005;125:833–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Collins P, Robinson DJ, Stringer MR, Stables GI, Sheehan-Dare RA. The variable response of plaque psoriasis after a single treatment with topical 5-aminolavelulinic acid photodynamic therapy. Br J Dermatol. 1997;137:743–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Robinson DJ, Collins P, Stringer MR, et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol. 1999;79(6):451–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Schleyer V, Radakovic-Fijan S, Karrer S, Zwingers T, Tanew A, Landthaler M, et al. Disappointing results and low tolerability of photodynamic therapy with topical 5-aminolaevulinic acid in psoriasis. A randomized, double-blind phase I/II study. J Eur Acad Dermatol Venereol. 2006;20(7):823–8.PubMedGoogle Scholar
  18. 18.
    Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V, et al. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer blinded study. Br J Dermatol. 2005;152(2):279–83.PubMedCrossRefGoogle Scholar
  19. 19.
    Fransson J, Ros AM. Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolaevulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed. 2005;21(6):326–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol. 1995;133:501–11.PubMedCrossRefGoogle Scholar
  21. 21.
    Robinson DJ, de Bruijn HS, de Wolf WF, et al. Topical 5-aminolevulenic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Photochem Photobiol. 2000;72:794–802.PubMedCrossRefGoogle Scholar
  22. 22.
    de Bruijn HS, van der Veen N, Robinson DJ, Star WM. Improvement of systemic 5-minolevulinic acid photodynamic therapy in-vivo using light fractionation with a 75-minute interval. Cancer Res. 1999;59:901–4.PubMedGoogle Scholar
  23. 23.
    Salah M, Samy N, Fadel M. Methylene blue mediated photodynamic therapy for resistant plaque psoriasis. J Drugs Dermatol. 2009;8(1):42–9.PubMedGoogle Scholar
  24. 24.
    Kessel D, Luo Y. Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol B. 1998;42(2):89–95.PubMedCrossRefGoogle Scholar
  25. 25.
    Kim JY, Kang HY, Lee ES, Kim YC. Topical 5-aminolaevulinic acid photodynamic therapy for intractable palmoplantar psoriasis. J Dermatol. 2007;34(1):37–40.PubMedCrossRefGoogle Scholar
  26. 26.
    Kim YC, Lee ES, Chung PS, Rhee CK. Recalcitrant palmoplantar pustular psoriasis successfully treated with topical 5-aminolaevulinic acid photodynamic therapy. Clin Exp Dermatol. 2005;30(6):723–4.CrossRefGoogle Scholar
  27. 27.
    Fernández-Guarino M, Harto A, Sánchez-Ronco M, García-Morales I, Jaén P. Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study. J Eur Acad Dermatol Venereol. 2009;23(8):891–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Thongprasom K, Dhanuthai K. Steroids in the treatment of lichen planus: a review. J Oral Sci. 2008;50(4):377–85.PubMedCrossRefGoogle Scholar
  29. 29.
    Aghahosseini F, Arbabi-Kalati F, Fashtami LA, Fateh M, Djavid GE. Treatment of oral lichen planus with photodynamic therapy mediated methylene blue: a case report. Med Oral Patol Oral Cir Bucal. 2006;11(2):E126–9.PubMedGoogle Scholar
  30. 30.
    Aghahosseini F, Arbabi-Kalati F, Fashtami LA, Djavid GE, Fateh M, Beitollahi JM. Methylene blue-mediated photodynamic therapy: a possible alternative treatment for oral lichen planus. Lasers Surg Med. 2006;38(1):33–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Hillemanns P, Untch M, Pröve F, Baumgartner R, Hillemanns M, Korell M. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol. 1999;93(1):71–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Vano-Galvan S, Fernandez-Guarino M, Beà-Ardebol S, Perez B, Harto A, Jaen P. Successful treatment of erosive vulvar lichen sclerosus with methylaminolaevulinic acid and laser-mediated photodynamic therapy. J Eur Acad Dermatol Venereol. 2009;23(1):71–2.PubMedCrossRefGoogle Scholar
  33. 33.
    Romero A, Hernández-Núñez A, Córdoba-Guijarro S, Arias-Palomo D, Borbujo-Martínez J. Treatment of recalcitrant erosive vulvar lichen sclerosus with photodynamic therapy. J Am Acad Dermatol. 2007;57(2 Suppl):S46–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Sotiriou E, Apalla Z, Patsatsi A, Panagiotidou D. Recalcitrant vulvar lichen sclerosis treated with aminolevulinic acid-photodynamic therapy: a report of five cases. J Eur Acad Dermatol Venereol. 2008;22(11):1398–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Sotiriou E, Panagiotidou D, Ioannidis D. An open trial of 5-aminolevulinic acid photodynamic therapy for vulvar lichen sclerosus. Eur J Obstet Gynecol Reprod Biol. 2008;141(2):187–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Zawislak AA, McCluggage WG, Donnelly RF, Maxwell P, Price JH, Dobbs SP, et al. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed. 2009;25(2):111–3.PubMedCrossRefGoogle Scholar
  37. 37.
    Alexiades-Armenakas M. Laser-mediated photodynamic therapy of lichen sclerosus. J Drugs Dermatol. 2004;3(6 Suppl):S25–7.PubMedGoogle Scholar
  38. 38.
    Passeron T, Lacour JP, Ortonne JP. Comparative treatment of extragenital lichen sclerosus with methylaminolevulinic acid pulsed dye laser-mediated photodynamic therapy or pulsed dye laser alone. Dermatol Surg. 2009;35(5):878–80.PubMedCrossRefGoogle Scholar
  39. 39.
    Karrer S, Abels C, Landthaler M, Szeimies RM. Topical photodynamic therapy for localized scleroderma. Acta Derm Venereol. 2000;80(1):26–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Herrmann G, Wlaschek M, Lange TS, Prenzel K, Goerz G, Scharffetter-Kochanek K. UVA irradiation stimulates the synthesis of various matrix metalloproteinases (MMP) in cultured human dermal fibroblasts. Exp Dermatol. 1993;2:92–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol. 2003;120(2):325–31.PubMedCrossRefGoogle Scholar
  42. 42.
    Berg K. Mechanism of cell damage in photodynamic therapy. In: Honigsmann H, Jori G, Young AR, editors. The fundamental bases of phototherapy. Milano: OEMF; 1996. p. 181–207.Google Scholar
  43. 43.
    Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical d-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol. 1997;66:493–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol. 2004;151(4):776–83.PubMedCrossRefGoogle Scholar
  45. 45.
    Batchelor R, Lamb S, Goulden V, Stables G, Goodfield M, Merchant W. Photodynamic therapy for the treatment of morphoea. Clin Exp Dermatol. 2008;33(5):661–3.PubMedCrossRefGoogle Scholar
  46. 46.
    Fernández-Guarino M, Harto A, Jaén P. Photodynamic therapy does not induce repigmentation in three cases of facial vitiligo. J Eur Acad Dermatol Venereol. 2008;22(12):1498–500.PubMedCrossRefGoogle Scholar
  47. 47.
    Serrano G, Lorente M, Reyes M, Millán F, Lloret A, Melendez J, et al. Photodynamic therapy with low-strength ALA, repeated applications and short contact periods (40–60 minutes) in acne, photoaging and vitiligo. J Drugs Dermatol. 2009;8(6):562–8.PubMedGoogle Scholar
  48. 48.
    Heidenheim M, Jemec GB. Successful treatment of necrobiosis lipoidica diabeticorum with photodynamic therapy. Arch Dermatol. 2006;142(12):1548–50.PubMedCrossRefGoogle Scholar
  49. 49.
    Berking C, Hegyi J, Arenberger P, Ruzicka T, Jemec GB. Photodynamic therapy of necrobiosis lipoidica – a multicenter study of 18 patients. Dermatology. 2009;218(2):136–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Karrer S, Abels C, Wimmershoff MB, Landthaler M, Szeimies RM. Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy. Arch Dermatol. 2002;138(5):581–4.PubMedCrossRefGoogle Scholar
  51. 51.
    Wilsmann-Theis D, Bieber T, Novak N. Photodynamic therapy as an alternative treatment for cutaneous sarcoidosis. Dermatology. 2008;217(4):343–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Kim YJ, Kang HY, Lee ES, Kim YC. Successful treatment of granuloma annulare with topical 5-aminolaevulinic acid photodynamic therapy. J Dermatol. 2006;33(9):642–3.PubMedCrossRefGoogle Scholar
  53. 53.
    Weisenseel P, Kuznetsov AV, Molin S, Ruzicka T, Berking C, Prinz JC. Photodynamic therapy for granuloma annulare: more than a shot in the dark. Dermatology. 2008;217(4):329–32.PubMedCrossRefGoogle Scholar
  54. 54.
    Bissonnette R, Shapiro J, Zeng H, McLean DI, Lui H. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata. Br J Dermatol. 2000;143(5):1032–5.PubMedCrossRefGoogle Scholar
  55. 55.
    Lee JW, Yoo KH, Kim BJ, Kim MN. Photodynamic therapy with methyl 5-aminolevulinate acid combined with microneedle treatment in patients with extensive alopecia areata. Clin Exp Dermatol. 2010;35:548–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Fernández-Guarino M, Harto A, García-Morales I, Pérez-García B, Arrazola JM, Jaén P. Failure to treat alopecia areata with photodynamic therapy. Clin Exp Dermatol. 2008;33(5):585–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Exadaktylou D, Kurwa HA, Calonje E, Barlow RJ. Treatment of Darier’s disease with photodynamic therapy. Br J Dermatol. 2003;149(3):606–10.PubMedCrossRefGoogle Scholar
  58. 58.
    van’t Westeinde SC, Sanders CJ, van Weelden H. Photodynamic therapy in a patient with Darier’s disease. J Eur Acad Dermatol Venereol. 2006;20(7):870–2.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Advanced DermatologyLincolnshireUSA
  2. 2.Department of DermatologyNorthwestern University Medical SchoolChicagoUSA

Personalised recommendations